Post PCI FFR

Much research has been done on the usefulness of functional testing such as fractional Flow reserve (FFR) after percutaneous coronary intervention (PCI), resulting in the correlation of pathological FFR values with major adverse events at 6 months, as shown by Pijls, et al.

The impact of post PCI FFR on prognosis has not been studied in contemporary cohorts, with the latest generation stents and in complex scenarios, such as multivessel disease, that can be treated both with PCI and coronary artery bypass graft (CABG). 

The FAME 3 study compared FFR guided multivessel PCI against CABG (excluding left main patients). This study did not reach non-inferiority for the composite of death, MI, stroke, or repeat revascularization. Despite these results, a subanalysis was conducted to assess the prognostic value of post PCI FFR in these patients.

Primary end point was target vessel failure (TVF) defined as the composite of cardiac death, target vessel MI and repeat revascularization at one year. 

Read also: Trans-Stent Gradient as a Predictor of Adverse Events at Followup.

Of the 1,500 FAME 3 patients, 757 were randomized to the FFR branch, and 61% of these pateints received post PCI FFR. As per protocol, there were no changes in therapy after the new measurement. 48% of measurements were from the anterior descending, 24.2% the circumflex and 27.6% the right coronary. Mean FFR value was 0.89 (RIC 0.85), and 9.1% of FFR cases was lower than 0.80. 

Multiple regression analysis showed predictors of post PCI FFR were male sex, anterior descending localization, minimal stent diameter and total stent length. Pathological post PCI FFR value were a predictor of target vessel failure (TVF) (HR=0.67, CI 95% 0.48-0.93, for 0.1 unit increase, p=0.165). A ROC curve analysis was done, which determined 0.88 as the best cutoff value to define TVF events.

Upon multivariable analysis, the independent factors of primary end point were kidney disease (HR 5.71, CI 95% 1.91-17.1, P=0.002) and continuously altered FFR values (HR 0.67, CI 0.49-0.91; P=0.03).

Read also: Severe Mitral Regurgitation and Cardiogenic Shock: Is Edge-to-Edge a Valid Strategy?

There was another analysis of patients receiving intravascular imaging (11.1% in the FFR branch FFR), which showed no higher rates of cardiac mortality, MI or repeat revascularization compared against patients not getting IVUS/OCT (log-rank P=0.21).

Conclusions

This FAME 3 subanalysis showed altered FFR values after PCI in patients with multivessel disease were a predictor of cardiovascular events, mainly due to target vessel failure at one year, while the use of intravascular imaging did not reduce the studied outcomes.  

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial.

Reference: Piroth, Zsolt et al. “Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial.” Circulation. Cardiovascular interventions vol. 15,11 (2022): 884-891. doi:10.1161/CIRCINTERVENTIONS.122.012542.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...